Vantage Market Research |
Innovative Collaborations and Approvals Drive Growth in Global Breast Cancer Therapeutics Market
Intensity Therapeutics Collaborates with SAKK on Phase 2 Trial
Intensity Therapeutics Inc., a late-stage clinical biotechnology company, has entered into a collaboration agreement with The Swiss Group for Clinical Cancer Research (SAKK) to conduct a Phase 2 randomized trial. The trial, named INVINCIBLE-4, will evaluate the clinical and biological effects of intratumoral INT230-6 followed by standard of care (SOC) immuno/chemotherapy versus SOC alone in early-stage triple-negative breast cancer (TNBC). This study will involve 54 patients in Switzerland and selected European countries. SAKK will act as the legal sponsor, while Intensity will fund the study and provide the investigational drug product.
Greenwich Life Sciences Expands Flamingo-01 Trial to Europe
Greenwich Life Sciences Inc., a clinical-stage biopharmaceutical company, has received approval to expand its Phase III clinical trial, Flamingo-01, into Europe. This trial evaluates GLSI-100, an immunotherapy aimed at preventing breast cancer recurrences. With formal approvals from Spain, France, Germany, Italy, and Poland, the company will activate 105 new clinical sites. The expansion highlights the growing collaboration within European academic networks, enhancing the trial's reach and potential impact on breast cancer treatment.
Gland Pharma Receives USFDA Approval for Eribulin Mesylate Injection
Gland Pharma has announced that it received approval from the United States Food and Drug Administration (USFDA) for its Eribulin Mesylate Injection, used to treat metastatic breast cancer. This approval marks the first generic entry of this product into the market. The 0.5 mg/ml single-dose vial is expected to launch soon through Gland Pharma's marketing partner. According to IQVIA, sales for this injection reached approximately USD 92 million as of February 2024, reflecting significant market demand.
Market Growth and Opportunities
The Global Breast Cancer Therapeutics Market is projected to reach USD 55.18 billion by 2032, growing at an impressive CAGR of 8.12%, according to Vantage Market Research. Several factors drive this growth, including continuous research efforts, advancements in targeted therapies and immunotherapies, and the global rise in breast cancer cases. Aging populations, lifestyle changes, and genetic factors further boost market expansion.
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Access Full Report
Innovative Collaborations and Approvals Drive Growth in Global Breast Cancer Therapeutics Market
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Healthcare
Veterinary Care Market Size, Share & Trends Analysis Report.
13 Nov 2023
10 Min Read
Healthcare
Surgical Imaging Market Size, Share & Trends Analysis Report.
13 Nov 2023
10 Min Read
Healthcare
Surgical Imaging Market Size, Share & Trends Analysis Report.
13 Nov 2023
10 Min Read
Latest Press Release
13 Nov 2023
Veterinary Care Market Size, Share & Trends Analysis Report.
Healthcare
13 Nov 2023
Surgical Imaging Market Size, Share & Trends Analysis Report.
Healthcare
13 Nov 2023
Surgical Imaging Market Size, Share & Trends Analysis Report.
Healthcare
Contact
Toll Free Number+1 (877) 462-2282